FendX Technologies (XCNQ:FNDX) Short Interest

View and export this data going back to 2023. Start your Free Trial

What is FendX Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of FendX Technologies's Short Interest

For the Specialty Chemicals subindustry, FendX Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FendX Technologies's Short Interest Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, FendX Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where FendX Technologies's Short Interest falls into.

FendX Technologies (XCNQ:FNDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » FendX Technologies Inc (XCNQ:FNDX) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

FDXTF:USA E8D:Germany

Address

2010 Winston Park Drive, 2nd Floor, Oakville, ON, CAN, L6H 5R7

Website

https://www.fendxtech.com

FendX Technologies Inc is a technology company focused on developing surface protection products that protect surfaces from pathogen contamination. It is focused on the research, development and commercialization of surface protection coatings using Licensed Technology. The company is currently developing its anticipated first product, REPELWRAP to protect high-contact surfaces from contamination to reduce the transmission of harmful pathogens. The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications.